Integrating Randomized Placebo-Controlled Trial Data with External Controls: A Semiparametric Approach with Selective Borrowing

06/29/2023
by   Chenyin Gao, et al.
0

In recent years, real-world external controls (ECs) have grown in popularity as a tool to empower randomized placebo-controlled trials (RPCTs), particularly in rare diseases or cases where balanced randomization is unethical or impractical. However, as ECs are not always comparable to the RPCTs, direct borrowing ECs without scrutiny may heavily bias the treatment effect estimator. Our paper proposes a data-adaptive integrative framework capable of preventing unknown biases of ECs. The adaptive nature is achieved by dynamically sorting out a set of comparable ECs via bias penalization. Our proposed method can simultaneously achieve (a) the semiparametric efficiency bound when the ECs are comparable and (b) selective borrowing that mitigates the impact of the existence of incomparable ECs. Furthermore, we establish statistical guarantees, including consistency, asymptotic distribution, and inference, providing type-I error control and good power. Extensive simulations and two real-data applications show that the proposed method leads to improved performance over the RPCT-only estimator across various bias-generating scenarios.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
03/08/2022

Testing for Treatment Effect Twice Using Internal and External Controls in Clinical Trials

Leveraging external controls – relevant individual patient data under co...
research
10/07/2021

A meta-analytic framework to adjust for bias in external control studies

While randomized controlled trials (RCTs) are the gold standard for esti...
research
05/10/2023

Case Weighted Adaptive Power Priors for Hybrid Control Analyses with Time-to-Event Data

We develop a method for hybrid analyses that uses external controls to a...
research
07/18/2019

Misplaced Confidence in Observed Power

A recently published randomized controlled trial in JAMA investigated th...
research
05/12/2023

A Causal Roadmap for Hybrid Randomized and Real-World Data Designs: Case Study of Semaglutide and Cardiovascular Outcomes

Introduction: Increasing interest in real-world evidence has fueled the ...

Please sign up or login with your details

Forgot password? Click here to reset